Stone Ridge Asset Management’s Gilead Sciences GILD Stock Holding History

Stone Ridge Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-150,000	Closed	-$11.5M	–	186
2020 Q2	$11.5M	Buy	+150,000	New	+$11.5M	1.84%	12
2019 Q2	–	Sell	-60,000	Closed	-$3.9M	–	1173
2019 Q1	$3.9M	Hold	60,000	–	–	0.22%	79
2018 Q4	$3.75M	Hold	60,000	–	–	0.23%	59
2018 Q3	$4.63M	Sell	60,000 -67,701	-53%	-$5.11M	0.25%	63
2018 Q2	$9.05M	Sell	127,701 -52,300	-29%	-$3.69M	0.52%	27
2018 Q1	$13.6M	Sell	180,001 -99,500	-36%	-$7.91M	0.79%	13
2017 Q4	$20M	Buy	+279,501	New	+$21.2M	1.25%	5
2016 Q2	–	Sell	-2,600	Closed	-$239K	–	23
2016 Q1	$239K	Hold	2,600	–	–	1.45%	28
2015 Q4	$263K	Hold	2,600	–	–	0.89%	42
2015 Q3	$255K	Hold	2,600	–	–	1.01%	43
2015 Q2	$304K	Hold	2,600	–	–	0.7%	39
2015 Q1	$255K	Hold	2,600	–	–	0.64%	70
2014 Q4	$245K	Buy	+2,600	New	+$269K	0.51%	77

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Stone Ridge Asset Management's GILD Position: Q3 2020 in Review

Stone Ridge Asset Management sold out of Gilead Sciences (GILD) in Q3 2020, closing a stake of 150,000 shares — an estimated $11.5M sold.

Stone Ridge Asset Management first reported a position in GILD in Q4 2014 and held it in 13 quarters. The position peaked at $20M in Q4 2017. 1,538 funds tracked by Wall St. Rank hold GILD as of Q3 2020.

Stone Ridge Asset Management reported no remaining Gilead Sciences position as of Q3 2020 after selling out during the quarter.
Stone Ridge Asset Management sold 150,000 Gilead Sciences shares in Q3 2020, an estimated $11.5M.
Stone Ridge Asset Management first reported a position in Gilead Sciences in Q4 2014 and held it in 13 quarters.
Stone Ridge Asset Management's Gilead Sciences position peaked at $20M in Q4 2017.
1,538 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2020.

Based on Stone Ridge Asset Management's 13F filing for Q3 2020.